… M. Kraft has served as a consultant and/or speaker for Astra-Zeneca, Genentech,
GlaxoSmithKline, Merck, Novartis, and Sepracor. She has received funding/grant support from …

… Other macrophage activators, such as phorbol esters or purified protein derivative from M.
tuberculosis, were not inhibited by this class of compounds. Thus, these compounds have …

… underlying balance between the strategies used by M. tuberculosis to survive within a host
and … phagocytes in response to inhaled M. tuberculosis. Archeological evidence indicates that …

Treatment is complex for patients with head and neck (H&N) cancers with specific site of
disease, stage, and pathologic findings guiding treatment decision-making. Treatment planning …

Despite significant advances in intensive care therapy and antibiotics, severe sepsis accounts
for 9% of all deaths in the United States annually. The pathological sequelae of sepsis are …

… Here open areas were dominated by shrubs less than 5 m tall. About 100 m from our sets
there was some forest with a canopy 4-8 m. Tree cbh averaged 22.8 ? 5.9 cm (N = 24) and …

… M. tuberculosis activates cells in a TLR-dependent manner, but unlike Gram-positive bacteria
and M… Unlike Gram-positive bacteria, TLR-dependent cellular activation by M. tuberculosis …

Toll-like receptor 2 (TLR2) agonists induce a subset of TLR4-inducible proinflammatory
genes, which suggests the use of differential signaling pathways. Murine macrophages …

A spectrophotometric procedure was developed using ashing at 450° C followed by acid
digestion in beakers and reading the diluted digests at 440 nm. Errors were minimized by …

In response to bacterial endotoxin (eg, LPS) or endogenous proinflammatory cytokines (eg,
TNF and IL-1β), innate immune cells release HMGB1, a late cytokine mediator of lethal …